Multiplex One-step kit for SARS-CoV-2, Influenza A & B

برای قیمت تماس بگیرید

AmirPayvand Research & Development Multiplex Screening Test Kit designed and manufactured for Rapid, Sensitive, and Specific Screening of Primary SARS-CoV-2 Infection and Influenza A, B and Their Differentiation in Upper and Lower Respiratory Samples of Patients with respiratory disease. The kit is fully competitive with the foreign qualified diagnostic kit in terms of accuracy, performance, and detection time, and for 3 genes N (belonging to SARS CoV-2), gene M (belonging to influenza A), and gene NS1 (belonging to Influenza type B) has a detection sensitivity (Limit of Detection) of 0.4 copies, 1.0 copies and 1.7 copies per microliter to detect the least amount of virus and in general, according to the electronic report sheet of health-oriented goods, has a sensitivity and specificity of 100% is applicable for the Multiplex One-step kit for SARS-CoV-2, Influenza A & B . In this kit, 4 pairs of primers and 4 props have been used to screen CoVID-19 classics of influenza A and B.

SKU: APSCFAB Categories: , ,

Description

Advantages and applications:

  • Officially licensed by the General Directorate of Medical Equipment of the Ministry of Health and Medical Education (IVD)
  • Evaluation of 3 specific genes:
    • N gene for SARS-CoV-2 detection, with detection sensitivity of 0.4Copy / µL
    • M gene for the diagnosis of influenza A, with a detection sensitivity of 1.0Copy / µL
    • NS1 gene for the diagnosis of influenza B, with a detection sensitivity of 1.7Copy / µL
  • Has internal control with CY5 label
  • Single-step without the need for cDNA synthesis
  • No need to prepare reagents
  • Optimal stability of the kit
Menu